Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Deep mutational scanning of the RBD from SARS-CoV-2 variant lineages using yeast display of barcoded libraries

PROVIDER: PRJNA770094 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR16287116.fastq.gz	Fastqsanger.gz
	SRR16287117.fastq.gz	Fastqsanger.gz
	SRR16287118.fastq.gz	Fastqsanger.gz
	SRR16287119.fastq.gz	Fastqsanger.gz
	SRR16287120.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 756

Similar Datasets

Project description:deep mutational scanning of the SARS-CoV-2 RBD using yeast display of barcoded libraries

| PRJNA639956 | ENA

Project description:Deep mutational scanning of SARS-related coronavirus RBDs using yeast display of barcoded libraries

| PRJNA962117 | ENA

Project description:Serum antibody binding to SARS-CoV-2 RBD variant libraries using yeast display

| PRJNA1264489 | ENA

SARS-CoV-2 pseudovirus strain:XBB.1.5

Project description:SARS-CoV-2 XBB.1.5 RBD-only pseudovirus based deep mutational scanning libraries

| PRJNA1035795 | ENA

Project description:High-throughput surveys of SARS-related coronavirus RBDs using yeast display of barcoded libraries

| PRJNA714677 | ENA

Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice

Project description:Global containment of COVID-19 still requires accessible and affordable vaccines for low- and middle-income countries (LMICs). Recently approved vaccines provide needed interventions, albeit at prices that may limit their global access. Subunit vaccines based on recombinant proteins are suited for large-volume microbial manufacturing to yield billions of doses annually, minimizing their manufacturing cost. These types of vaccines are well-established, proven interventions with multiple safe and efficacious commercial examples. Many vaccine candidates of this type for SARS-CoV-2 rely on sequences containing the receptor-binding domain (RBD), which mediates viral entry to cells via ACE2. Here we report an engineered sequence variant of RBD that exhibits high-yield manufacturability, high-affinity binding to ACE2, and enhanced immunogenicity after a single dose in mice compared to the Wuhan-Hu-1 variant used in current vaccines. Antibodies raised against the engineered protein exhibited heterotypic binding to the RBD from two recently reported SARS-CoV-2 variants of concern (501Y.V1/V2). Presentation of the engineered RBD on a designed virus-like particle (VLP) also reduced weight loss in hamsters upon viral challenge.

2021-09-09 | GSE172054 | GEO

Project description:High-throughput deep mutational scanning of SARS-CoV-2 RBD neutralizing antibodies for epitope identification and antibody classification with yeast surface display and MACS-based selection. Raw sequence reads

| PRJNA787091 | ENA

Peripheral Blood Mononuclear Cell Electrophysiology as a Marker for Immune Response to Exposure and Vaccination

Project description:Comparison of cell stimulated with SARS-CoV-2 RBD, peptide mix or control. Samples from 3 donors post second vaccine dose.

2025-04-01 | E-MTAB-14606 | biostudies-arrayexpress

Project description:Yeast cytosine deaminase (FCY1) deep mutational scanning

| PRJNA782569 | ENA

Project description:Making deep mutational scanning accessible: a cost-efficient approach to construct barcoded libraries for genes of any length

| PRJNA1269095 | ENA